Adam, the "Dividend Sensei" and I sit down to discuss Gilead (GILD). Adam provides a fire hydrant blast of information and expectations regarding Gilead, including some thoughts on the possibility of Gilead being acquired.
If you'd like to jump ahead in the interview to the discussion on Gilead's acquisition prospects, it begins around the 20 minute mark of the interview.
A quick overview:
Companies Mentioned: Pfizer (PFE), JNJ (JNJ), Merck (MRK), Amgen (AMGN), AstraZeneca (AZN), AbbVie (ABBV)